LBL-007
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for LBL-007, covering 2025-06-03 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors [Phase 1, Phase 2]